We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Gradual Cryopreservation Becoming a Possibility

By Biotechdaily staff writers
Posted on 28 Jun 2006
A new study with water--still one of the least understood of all liquids in spite of a century of concentrated research--seems to back up the possibility that cells, tissues, and even the total human body could be cyropreserved without the formation of destructive ice crystals.

University of Helsinki (Finland) researcher Anatoli Bogdan, Ph.D., performed the study, which will be published in the July 6, 2006, issue of the Journal of Physical Chemistry B. More...
Medically, cryopreservation involves preserving organs and tissues for transplantation or other uses. Only specific types of cells and tissues, including sperm and embryos, currently can be frozen and effectively rewarmed. A major obstacle hampering expanded use of cyropreservation is the formation of ice crystals, which damage cell structures. Cyropreservation may be most recognizable, however, as the controversial hypothesis that humans, suffering with incurable diseases, might be frozen and then revived years or decades later when cures are available.

Dr. Bogdan's studies involved a form of water called "glassy water,” or low-density amorphous (LDA) ice, which is generated by gradually supercooling diluted aqueous droplets. LDA melts into highly viscous water (HVW). Dr. Bogdan reported that HVW is not a new form of water, as some scientists believed.

"That HVW is not a new form of water [i.e., normal and glassy water are thermodynamically connected] may have some interesting practical implications in cryobiology, medicine, and cryonics,” Dr. Bogdan said. "It may seem fantastic, but the fact that in aqueous solution, [the] water component can be slowly supercooled to the glassy state and warmed back without the crystallization implies that, in principle, if the suitable cyroprotectant is created, cells in plants and living matter could withstand a large supercooling and survive.”

In present cyropreservation, the cells being preserved are often damaged due to freezing of water either on cooling or subsequent warming to room temperature. "Damage of the cells occurs due to the extra-cellular and intra-cellular ice formation, which leads to dehydration and separation into the ice and concentrated unfrozen solution. If we could, by slow cooling/warming, super cool, and then warm the cells without the crystallization of water then the cells would be undamaged,” stated Dr. Bogdan.



Related Links:
University of Helsinki

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rheumatoid Factors (RF) Test
Rheumatoid Factors (RF)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.